← Back to all trials
Not Yet Recruiting
NCT05755607
A Multicenter Prospective Randomized Controlled Study of RPD Versus LPD
Conditions: Pancreatic Cancer, Common Bile Duct Diseases, Periampullary Carcinoma
Sex: All
Ages: 18 Years – N/A
Phase: NA
Enrollment: 200
Sponsor: The First Affiliated Hospital of University of South China
Summary
laparoscopic pancreaticoduodenectomy(LPD) and Robot Pancreaticoduodenectomy (RPD), as two minimally invasive methods of pancreaticoduodenectomy(PD), have obvious advantages over traditional open pancreaticoduodenectomy(OPD) in terms of reducing surgical trauma and hospitalization time, but there are few studies on their perioperative safety and prognostic effects.However, there are few studies on the perioperative safety and prognostic effects of both procedures.
In this trial, the perioperative data and prognosis of both procedures were collected and analyzed through a prospective, multicenter approach to investigate the advantages and disadvantages of both procedures.
Eligibility Criteria
Inclusion Criteria:Over 18 years oldPreoperative imaging suggested the presence of space occupying in the head of the pancreas, ampullary abdomen, and distal common bile duct tumor lesions to be treated with PancreaticoduodenectomyNo distant transferNo significant vascular invasion was receivedExclusion Criteria:With tumors of other organsPatients unable to tolerate anesthesia and operation due to serious abnormalities in functions of heart, lung and other important organsPatients found intraoperative peripheral organ metastasis combined with excision of other organs or found intraoperative radical excision could not be performed and underwent palliative drainage surgery or end the surgeryPreoperative adjuvant therapy was given
Source: ClinicalTrials.gov (NCT05755607). StuddyBuddy aggregates publicly available trial information.